Patient-Funded Trials: Opportunity or Liability?

Cell Stem Cell 17 (2):135-137 (2015)
  Copy   BIBTEX


Patient-funded trials are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols

Similar books and articles

Clinical trials--a brave new partnership?H. Thornton - 1994 - Journal of Medical Ethics 20 (1):19-25.
Polishing Up the Pinto.John R. Danley - 2005 - Business Ethics Quarterly 15 (2):205-236.
Palliative care and cancer trials.S. M. Brown - 2003 - Journal of Medical Ethics 29 (6):371-371.


Added to PP

369 (#38,962)

6 months
24 (#77,896)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Alex John London
Carnegie Mellon University
Danielle M. Wenner
Carnegie Mellon University

References found in this work

Add more references